Abstract
Skin exposure to sensitizing chemicals can induce allergic reactions. Certain chemicals, so called pro-sensitizers, need metabolic activation to become allergenic. Their metabolic activation occurs in skin cells such as keratinocytes or dendritic cells. These cell types are also incorporated into dermal in vitro test systems used to assess the sensitizing potential of chemicals for humans. In vitrosystems range from single cell cultures to organotypic multi-cellular reconstructed skin models. Until now, their metabolic competence to unmask sensitizing potential of pro-sensitizers was rarely investigated. This review aims to summarize current information on available skin in vitro models and the relevance of xenobiotic metabolizing enzymes for the activation of pro-sensitizers such as eugenol, 4-allylanisole, and ethylendiamine. Among others, these chemicals are discussed as performance standards to validate new coming in vitro systems for their potential to identify pro-sensitizers. © 2012 Informa Healthcare USA, Inc.
Author supplied keywords
Cite
CITATION STYLE
Jäckh, C., Fabian, E., Van Ravenzwaay, B., & Landsiedel, R. (2012, December). Relevance of xenobiotic enzymes in human skin in vitro models to activate pro-sensitizers. Journal of Immunotoxicology. https://doi.org/10.3109/1547691X.2012.664578
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.